Nisa Investment Advisors LLC Has $390,000 Stock Holdings in Lemonade, Inc. (NYSE:LMND)

Nisa Investment Advisors LLC grew its holdings in Lemonade, Inc. (NYSE:LMNDFree Report) by 4.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 10,640 shares of the company’s stock after acquiring an additional 500 shares during the quarter. Nisa Investment Advisors LLC’s holdings in Lemonade were worth $390,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Blue Trust Inc. increased its holdings in Lemonade by 220.0% in the third quarter. Blue Trust Inc. now owns 2,733 shares of the company’s stock worth $45,000 after purchasing an additional 1,879 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. raised its position in shares of Lemonade by 321.3% during the 3rd quarter. Point72 Asia Singapore Pte. Ltd. now owns 4,462 shares of the company’s stock valued at $74,000 after buying an additional 3,403 shares in the last quarter. Johnson & White Wealth Management LLC purchased a new stake in shares of Lemonade in the 4th quarter valued at $234,000. Quest Partners LLC raised its holdings in Lemonade by 1,647.6% during the 3rd quarter. Quest Partners LLC now owns 9,105 shares of the company’s stock valued at $150,000 after buying an additional 8,584 shares during the last quarter. Finally, Mandatum Life Insurance Co Ltd bought a new stake in Lemonade in the fourth quarter valued at $378,000. Institutional investors own 80.30% of the company’s stock.

Lemonade Price Performance

Shares of Lemonade stock opened at $33.41 on Thursday. The company has a market capitalization of $2.39 billion, a PE ratio of -10.99 and a beta of 2.17. The business has a 50-day moving average of $39.96 and a 200-day moving average of $27.07. Lemonade, Inc. has a 1-year low of $14.03 and a 1-year high of $53.85.

Lemonade (NYSE:LMNDGet Free Report) last released its earnings results on Wednesday, October 30th. The company reported ($0.95) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($1.02) by $0.07. The firm had revenue of $136.60 million for the quarter, compared to analyst estimates of $129.10 million. Lemonade had a negative return on equity of 32.85% and a negative net margin of 43.51%. Lemonade’s revenue was up 19.3% compared to the same quarter last year. During the same period in the previous year, the company earned ($0.88) earnings per share. On average, equities analysts expect that Lemonade, Inc. will post -3.06 earnings per share for the current fiscal year.

Insider Transactions at Lemonade

In other Lemonade news, major shareholder Softbank Group Capital Ltd sold 719,815 shares of the stock in a transaction dated Monday, December 16th. The shares were sold at an average price of $44.29, for a total value of $31,880,606.35. Following the transaction, the insider now directly owns 11,263,569 shares of the company’s stock, valued at $498,863,471.01. This represents a 6.01 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider John Sheldon Peters sold 1,790 shares of the firm’s stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $45.50, for a total value of $81,445.00. Following the transaction, the insider now owns 88,493 shares in the company, valued at approximately $4,026,431.50. This trade represents a 1.98 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 900,499 shares of company stock worth $39,114,376. 12.50% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several analysts have commented on the company. JMP Securities increased their target price on Lemonade from $40.00 to $60.00 and gave the company a “market outperform” rating in a research note on Friday, November 22nd. BMO Capital Markets boosted their price objective on Lemonade from $13.00 to $15.00 and gave the stock an “underperform” rating in a research note on Thursday, November 21st. Morgan Stanley raised shares of Lemonade from an “underweight” rating to an “equal weight” rating and raised their price target for the stock from $23.00 to $42.00 in a research note on Wednesday, November 20th. Piper Sandler upped their price objective on Lemonade from $25.00 to $44.00 and gave the stock a “neutral” rating in a research note on Thursday, November 21st. Finally, Keefe, Bruyette & Woods lowered Lemonade from a “market perform” rating to an “underperform” rating and raised their target price for the stock from $18.00 to $21.00 in a research note on Thursday, November 7th. Three investment analysts have rated the stock with a sell rating, two have assigned a hold rating and one has given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $32.67.

Read Our Latest Analysis on LMND

Lemonade Profile

(Free Report)

Lemonade, Inc provides various insurance products through various channels in the United States, Europe, and the United Kingdom. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property.

Featured Articles

Want to see what other hedge funds are holding LMND? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lemonade, Inc. (NYSE:LMNDFree Report).

Institutional Ownership by Quarter for Lemonade (NYSE:LMND)

Receive News & Ratings for Lemonade Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lemonade and related companies with MarketBeat.com's FREE daily email newsletter.